Medication info
Pregabalin Capsule 75mg (Pregabalin)

Pregabalin Capsule 75mg (Pregabalin)

Prescription medicationHard capsuleOral
Ingredient · strength
Pregabalin›75mg / 1 capsule
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
A hard capsule with a reddish-brown upper part and a white lower part containing a white or light yellow powder.
Packaging
30 capsules/bottle, 60 capsules/bottle
Approval status
Active

MFDS item code 201603620 · Approved 2016.06.20 · Insurance code 628900850

Summary

Main use
Treatment of neuropathic pain, adjunctive treatment of partial-onset seizures, treatment of fibromyalgia
Who takes it
Adults · Children
Adult dose
Administer the total daily dose of this medicine, as pregabalin, orally in 2 divided doses, with or without food. This medicine is primarily excreted by the kidneys, so the dose should be adjusted in patients with impaired renal function. Peripheral neuropathic pain - Adults: This medicine may be started at 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg/day. Central neuropathic pain - Adults: This medicine may be started at 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, it may be increased to the target dose of 600 mg/day. If the target daily dose is not tolerated, a dose reduction may be considered. Epilepsy - Adults: This medicine may be started at 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg/day. The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. Patients with renal impairment: Dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance (CLcr) ≥60 (mL/min): Starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr) ≥30 -<60 (mL/min): Starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr) ≥15 -<30 (mL/min): Starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr) <15 (mL/min): Starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: Starting dose 25, maximum dose 100, single dose b In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the method of administration. b: The supplemental dose is an additional dose administered once. No dose adjustment is necessary in patients with hepatic impairment. Elderly patients (aged 65 years and older): Dose reduction may be necessary in elderly patients with impaired renal function.
Child dose
Children under 12 years of age: Use is not recommended. Adolescent patients aged 12 ~17 years: Use is not recommended.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of neuropathic pain, adjunctive treatment of partial-onset seizures, treatment of fibromyalgia

  • Peripheral neuropathic pain
  • central neuropathic pain
  • partial seizures
  • fibromyalgia
View approved original text

This medication is used to treat peripheral and central neuropathic pain in adults and serves as an adjunctive therapy for partial seizures in patients with epilepsy. It is also effective in the treatment of fibromyalgia. It helps improve the symptoms of patients suffering from these various neurological disorders.

How to take

Adult dose

Administer the total daily dose of this medicine, as pregabalin, orally in 2 divided doses, with or without food. This medicine is primarily excreted by the kidneys, so the dose should be adjusted in patients with impaired renal function. Peripheral neuropathic pain - Adults: This medicine may be started at 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg/day. Central neuropathic pain - Adults: This medicine may be started at 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, it may be increased to the target dose of 600 mg/day. If the target daily dose is not tolerated, a dose reduction may be considered. Epilepsy - Adults: This medicine may be started at 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg/day. The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. Patients with renal impairment: Dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance (CLcr) ≥60 (mL/min): Starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr) ≥30 -<60 (mL/min): Starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr) ≥15 -<30 (mL/min): Starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr) <15 (mL/min): Starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: Starting dose 25, maximum dose 100, single dose b In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the method of administration. b: The supplemental dose is an additional dose administered once. No dose adjustment is necessary in patients with hepatic impairment. Elderly patients (aged 65 years and older): Dose reduction may be necessary in elderly patients with impaired renal function.

Child dose

Children under 12 years of age: Use is not recommended. Adolescent patients aged 12 ~17 years: Use is not recommended.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes occur during use, consult a doctor immediately. Individuals with allergies to the ingredients of this medication or those with certain genetic disorders should not use this product. Diabetic patients may need adjustments to the dosage of blood glucose controlling medications due to weight gain after taking this medication. If swelling around the face or mouth occurs during treatment, discontinue use and seek medical attention. Elderly patients may experience symptoms such as dizziness, drowsiness, or confusion while taking this medication, and caution should be exercised; if these symptoms occur, activities should be approached carefully. If there is blurriness of vision or changes in eyesight, discontinuing this medication may improve symptoms. If this medication is stopped suddenly after long-term use, withdrawal symptoms such as insomnia, headache, nausea, and anxiety may occur, so it should be gradually reduced according to a doctor’s instructions. Due to the risk of drug abuse, patients with a history of mental illness or substance abuse should exercise caution. Patients with impaired kidney function should have their dosage adjusted, and dose adjustments may also be needed after renal function improves. Patients with heart disease may experience worsening heart failure symptoms while taking this medication, so consultation with a physician is necessary. Caution is advised when taking this medication with opioid analgesics, as it may increase central nervous system depressant effects, posing risks such as respiratory suppression. Pregnant women or those planning to become pregnant should consult a doctor before use, as this medication may affect the fetus, and effective contraception should be practiced. Breastfeeding women should avoid breastfeeding while taking this medication, as it may be transmitted through breast milk and affect the baby. Caution should be exercised when driving or operating machinery, as this medication may cause dizziness or drowsiness. Severe skin reactions may occur rarely with this medication; if any rash, redness, or blisters develop on the skin, discontinue use immediately and inform a physician. In case of overdose, confusion, drowsiness, or depression may arise, and treatment such as blood dialysis may be necessary if required. This medication should be kept out of reach of children, and transferring to other containers should be avoided.

Side effects

  • Suicidal thoughts
  • suicidal behavior
  • depression
  • angioedema
  • facial swelling
  • perioral edema
  • upper airway edema
  • dizziness
  • drowsiness
  • loss of consciousness
Show 191 more
  • confusion
  • mental disturbance
  • blurred vision
  • vision changes
  • insomnia
  • headache
  • nausea
  • anxiety
  • diarrhea
  • influenza-like illness
  • restlessness
  • thoughts of suicide
  • pain
  • seizures
  • excessive sweating
  • misuse
  • abuse
  • dependence
  • congestive heart failure
  • severe respiratory depression
  • rhinitis
  • neutropenia
  • increased appetite
  • anorexia
  • hypoglycemia
  • confusion
  • spatial disorientation
  • irritability
  • feelings of euphoria
  • decreased libido
  • depersonalization
  • paraphilia
  • agitation
  • mood instability
  • emotional blunting
  • emotional elevation
  • hallucinations
  • abnormal dreams
  • increased libido
  • panic attacks
  • impulse control disorder
  • apathy
  • ataxia
  • coordination disorders
  • balance disorders
  • amnesia
  • attention deficit
  • memory impairment
  • tremors
  • dysarthria
  • sensory abnormalities
  • sensory loss
  • sedation
  • somnolence
  • cognitive impairment
  • nystagmus
  • speech disorders
  • fasciculations
  • reflex decrease
  • movement disorders
  • psychomotor agitation
  • positional dizziness
  • hypersensitivity
  • burning sensation
  • activity tremors
  • syncope
  • confusion
  • hypokinesia
  • olfactory disturbances
  • loss of taste
  • writing difficulties
  • blurred vision
  • diplopia
  • indirect vision loss
  • visual disturbances
  • visual field defects
  • photophobia
  • dry eyes
  • eye swelling
  • decreased vision
  • eye pain
  • eye fatigue
  • increased tear secretion
  • eye irritation
  • mydriasis
  • during vibration
  • changes in depth perception
  • strabismus
  • brightness of vision
  • vertigo
  • auditory hypersensitivity
  • first-degree AV block
  • tachycardia
  • sinus bradycardia
  • sinus tachycardia
  • sinus arrhythmia
  • hypotension
  • hypertension
  • flushing
  • facial flushing
  • peripheral coldness
  • dyspnea
  • epistaxis
  • cough
  • nasal congestion
  • rhinitis
  • snoring
  • pharyngeal tension
  • nasal dryness
  • respiratory depression
  • vomiting
  • abdominal distention
  • constipation
  • dry mouth
  • flatulence
  • hypersalivation
  • gastroesophageal reflux disease
  • oral sensory loss
  • ascites
  • dysphagia
  • pancreatitis
  • sweating
  • papular rash
  • urticaria
  • cold sweats
  • muscle cramps
  • arthralgia
  • back pain
  • limb pain
  • cervical spasms
  • joint swelling
  • myalgia
  • muscle spasms
  • neck pain
  • muscle rigidity
  • rhabdomyolysis
  • urinary disorders
  • urinary incontinence
  • decreased urination
  • renal failure
  • erectile dysfunction
  • delayed ejaculation
  • sexual dysfunction
  • dysmenorrhea
  • amenorrhea
  • mastalgia
  • breast discharge
  • breast enlargement
  • peripheral edema
  • edema
  • gait abnormalities
  • falls
  • feeling intoxicated
  • altered sensation
  • fatigue
  • chest tightness
  • generalized edema
  • pain
  • fever
  • chills
  • weakness
  • thirst
  • weight gain
  • increased alanine aminotransferase
  • increased serum creatine phosphokinase
  • increased aspartate aminotransferase
  • increased blood glucose
  • decreased platelet count
  • decreased serum potassium
  • weight loss
  • increased serum creatinine
  • decreased leukocyte count
  • hypersensitivity
  • allergic reactions
  • headache
  • keratitis
  • pulmonary edema
  • nausea
  • diarrhea
  • tongue swelling
  • itching
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • lassitude
  • delirium
  • paralysis
  • affective disorders
  • instability
  • restlessness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent ingress of air or moisture. Additionally, it is important to store it in a cool area between 15 to 30 degrees Celsius to maintain effectiveness.

Appearance and packaging

Appearance

A hard capsule with a reddish-brown upper part and a white lower part containing a white or light yellow powder.

Package unit

30 capsules/bottle, 60 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.